pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Episodes
![Building agile partner relationships at a vaccine-focused biotech](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-62-1400x1400_300x300.jpg)
Thursday Oct 13, 2022
Thursday Oct 13, 2022
In this episode of the pharmaphorum, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health.
![Understanding the tumour micro-environment – the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-61-1400x1400_300x300.jpg)
Thursday Oct 06, 2022
Thursday Oct 06, 2022
Dr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give us a primer on the tumour micro-environment, what it is, how we understand it, and what it means for the future of cancer care.
![How a once-weekly insulin could disrupt diabetes management](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-60-1400x1400_300x300.jpg)
Thursday Sep 22, 2022
Thursday Sep 22, 2022
In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.
![How these parents of a child with a rare disease are making precision medicine work for them](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-59-1400x1400_300x300.jpg)
Thursday Sep 08, 2022
Thursday Sep 08, 2022
In today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the story of their new nonprofit Moonshots for Unicorns, which sets up a framework for parents in their circumstance to directly crowdfund research for rare single-gene disorders – starting with PGAP3.
![AI-derived cancer vaccines](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-58-1400x1400_300x300.jpg)
Thursday Aug 25, 2022
Thursday Aug 25, 2022
Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular.
![Challenges and opportunities in the off-patent sector](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-57-1400x1400_300x300.jpg)
Thursday Aug 11, 2022
Thursday Aug 11, 2022
In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz.
Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patient stories behind the headlines and the effect of COVID-19 on the generics market.
![Building a digital therapeutic for paediatric behavioural health opioids](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-56-1400x1400_300x300.jpg)
Thursday Jul 28, 2022
Thursday Jul 28, 2022
On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss his company’s digital therapeutic for teen depression.
![Gene silencing and mRNA: breakthroughs and barriers](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-55-1400x1400_300x300.jpg)
Thursday Jul 14, 2022
Thursday Jul 14, 2022
On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular design at Silence Therapeutics.
![Rethinking pharmaceutical pain management beyond opioids](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/MicrosoftTeams-image_300x300.jpg)
Tuesday Jul 05, 2022
Tuesday Jul 05, 2022
On the latest installment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio.
![Why diverse clinical trials matter](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-53-1400x1400_300x300.jpg)
Thursday Jun 16, 2022
Thursday Jun 16, 2022
In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.